P1063: EFFICACY AND SAFETY OF PARSACLISIB-RUXOLITINIB COMBINATION THERAPY IN MYELOFIBROSIS PATIENTS WITH LOW VS HIGHER BASELINE PLATELET COUNT: A SUBGROUP ANALYSIS OF DATA FROM A PHASE 2 STUDY

ABSTRACT:

SUBMITTER: Yacoub A 

PROVIDER: S-EPMC9430537 | biostudies-literature | 2022 Jun

REPOSITORIES: biostudies-literature